Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Bio-PRF

PreclinicalBiologic

UUniversity of Dublin, Trinity College

Bio-PRF is one of 2 biologic programs targeting Alveolar Osteitis. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

Alveolar OsteitisUnknown status

Alveolar OsteitisPreclinical

Unknown status

Competition

Competitive Landscape

2 competitors in Alveolar Osteitis

#DrugCompanyPhaseTrials

Alvogyl

WWatim Medical & Dental College

Bio-PRF

UUniversity of Dublin, Trinity College

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Alveolar Osteitis1 trial

Treatment of Alveolar Osteitis: Traditional or Regenerative?

Unknown status·UUniversity of Dublin, Trinity College·N/A·NCT05615272·58 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Bio-PRF. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bio-PRF compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bio-PRF. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Dublin, Trinity College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Dublin, Trinity College

Related News